Northwest Arkansas Democrat-Gazette

Walmart pulls Zantac-related drugs

- Informatio­n for this article was contribute­d by staff members of The Associated Press, by Timothy Annett of Bloomberg News and by Sandra E. Garcia of The New York Times.

Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentiall­y dangerous contaminan­t in the drug.

The nation’s largest retailer said Wednesday that it suspended sales of all drugs sold over the counter, or without a prescripti­on, that include Zantac’s active ingredient, ranitidine. Aside from Zantac, that includes Equate and Member’s Mark brands.

The U.S. Food and Drug Administra­tion said last month it detected low levels of nitrosodim­ethylamine, a suspected cancercaus­ing chemical, in Zantac and related generic drugs to treat ulcers and reflux disease. The same chemical has been linked to dozens of recalls of prescripti­on

blood pressure drugs in the past year. That has sparked a recall of millions of pills in about 30 countries.

The drugstore chains CVS Health, Walgreens and Rite Aid have already pulled Zantac products from their shelves.

French drug giant Sanofi makes branded Zantac.

A recent series of drug recalls has raised concerns about the safety and integrity of the U.S. drug-supply chain and the capacity of regulators to adequately police a sprawling global network of pharmaceut­ical suppliers.

Walmart said patients could return the drugs to its Walmart and Sam’s Club stores for a refund. Walmart has pharmacies in thousands of its U.S. stores. The FDA has advised consumers who take ranitidine medication­s for heartburn and other stomach ailments to consider alternativ­e therapies while the agency investigat­es the suspected contaminat­ion.

Some versions of Zantac have been recalled in the U.S. by manufactur­ers. Canadian generic-drug maker Apotex Inc. recalled ranitidine that it made for Walmart, Rite Aid and Walgreens last month. Novartis AG’s Sandoz unit recalled generic prescripti­on ranitidine in the U.S. after detecting elevated levels of nitrosodim­ethylamine, a type of nitrosamin­e.

Nitrosamin­es can cause tumors in the liver and other organs in lab animals, and they are believed to be carcinogen­ic in humans. Nitrosodim­ethylamine can form during manufactur­ing if the chemical reactions used to make the drug are not carefully controlled, the FDA has said.

Ranitidine is a histamine blocker that works to lower the acid created in the stomach, according to the FDA. The medication is sometimes prescribed to prevent ulcers of the stomach and intestines as well as gastroesop­hageal reflux disease, the agency says.

The European Medicines Agency is also reviewing the drug. Canada has ordered a halt to all distributi­on of ranitidine while it investigat­es.

 ?? AP ?? Walmart Inc. has suspended the sale of all over-the-counter versions of the gastric-acid blocker ranitidine, the active ingredient in Zantac, over concern that some may contain cancer-causing contaminan­ts.
AP Walmart Inc. has suspended the sale of all over-the-counter versions of the gastric-acid blocker ranitidine, the active ingredient in Zantac, over concern that some may contain cancer-causing contaminan­ts.

Newspapers in English

Newspapers from United States